In the present study, SKO-001 administration resulted in reduced adipocyte size, along with increased levels of UCP-1, an important marker of browning, suggesting that SKO-001 may induce adipocyte browning, which may partly contribute to its anti-obesity effects by stimulating energy metabolism. This evidence concerns the gene UCP1 and obesity due to melanocortin 4 receptor deficiency.